Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 2/20 | 0.50 |
| ▸ | GJB2 | P29033 | 1/20 | 0.50 |
| ▸ | TLR4 | O00206 | 4/20 | 0.49 |
| ▸ | TK2 | O00142 | 2/20 | 0.49 |
| ▸ | LY96 | Q9Y6Y9 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4199470 | 1.00 | LGALS8 (0.50) | LGALS8GJB2TLR4TK2LY96 | |
| SCHEMBL4185270 | 1.00 | LGALS8 (0.50) | LGALS8GJB2TLR4TK2LY96 | |
| SCHEMBL4181285 | 1.00 | LGALS8 (0.50) | LGALS8GJB2TLR4TK2LY96 | |
| SCHEMBL3393533 | 1.00 | LGALS8 (0.50) | LGALS8GJB2TLR4TK2LY96 | |
| SCHEMBL3388849 | 1.00 | LGALS8 (0.50) | LGALS8GJB2TLR4TK2LY96 | |
| SCHEMBL2959758 | 0.93 | TLR4 (0.54) | GJB2TLR4 | |
| SCHEMBL4181281 | 0.93 | GJB2 (0.50) | GJB2TLR4TK2LY96 | |
| SCHEMBL3393530 | 0.93 | GJB2 (0.50) | GJB2TLR4TK2LY96 | |
| SCHEMBL4199466 | 0.93 | GJB2 (0.50) | GJB2TLR4TK2LY96 | |
| SCHEMBL3388845 | 0.93 | GJB2 (0.50) | GJB2TLR4TK2LY96 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090098172-A1 | SURFACTANT, AND EMULSION COSMETIC AND LIPOSOME EACH CONTAINING THE SAME | KAO CORPORATION (JP) | 2009-04-16 | — | — | US | disclosed |
| US-20070292462-A1 | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant | KAO CORPORATION (JP) | 2007-12-20 | — | — | US | disclosed |
| US-20070160556-A1 | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant | IKEMOTO TAKESHI | 2007-07-12 | — | — | US | disclosed |
| US-20050220726-A1 | Use of sugar esters in cosmetic and/or pharmaceutical preparations | COGNIS FRANCE S.A. (FR) | 2005-10-06 | — | — | US | disclosed |
| US-6497898-B1 | STABILITY, DRUG AND COSMETIC DELIVERY | KANEBO LTD (JP) | 2002-12-24 | — | — | US | disclosed |
| EP-0729781-B1 | LIPOSOME COMPRISING A MEMBRANE WALL COMPOSED OF A TREHALOSE FATTY ACID ESTER | KANEBO LTD (JP) | 2002-08-07 | — | — | EP | disclosed |
| EP-0729781-A1 | SURFACTANT, AND EMULSION COSMETIC AND LIPOSOME EACH CONTAINING THE SAME | Ikemoto, Takeshi (JP) | 1996-09-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070292462-A1 | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant | TREH, LIPA, CUTA | LGALS8 806/4885GJB2 4097/4885TLR4 477/4885 |
| US-20070160556-A1 | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant | TREH, LIPA, CUTA | LGALS8 806/4885GJB2 4097/4885TLR4 477/4885 |
| US-20090098172-A1 | SURFACTANT, AND EMULSION COSMETIC AND LIPOSOME EACH CONTAINING THE SAME | TREH, LIPA, SGMS1 | LGALS8 983/4885GJB2 4241/4885TLR4 513/4885 |
| US-20050220726-A1 | Use of sugar esters in cosmetic and/or pharmaceutical preparations | CUTA, SUCLG1, TREH | LGALS8 175/4885GJB2 3366/4885TLR4 2866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.